Externally controlled on-demand release of anti-HIV drug using magneto-electric nanoparticles as carriers

Although highly active anti-retroviral therapy has resulted in remarkable decline in the morbidity and mortality in AIDS patients, inadequately low delivery of anti-retroviral drugs across the blood-brain barrier results in virus persistence. The capability of high-efficacy-targeted drug delivery and on-demand release remains a formidable task. Here we report an in vitro study to demonstrate the on-demand release of azidothymidine 5'-triphosphate, an anti-human immunodeficiency virus drug, from 30 nm CoFe2O4@BaTiO3 magneto-electric nanoparticles by applying a low alternating current magnetic field. Magneto-electric nanoparticles as field-controlled drug carriers offer a unique capability of field-triggered release after crossing the blood-brain barrier. Owing to the intrinsic magnetoelectricity, these nanoparticles can couple external magnetic fields with the electric forces in drug-carrier bonds to enable remotely controlled delivery without exploiting heat. Functional and structural integrity of the drug after the release was confirmed in in vitro experiments with human immunodeficiency virus-infected cells and through atomic force microscopy, spectrophotometry, Fourier transform infrared and mass spectrometry studies.

[1]  N. Mathur,et al.  Multiferroic and magnetoelectric materials , 2006, Nature.

[2]  R. Langer,et al.  Photoswitchable Nanoparticles for Triggered Tissue Penetration and Drug Delivery , 2012, Journal of the American Chemical Society.

[3]  Brian P. Timko,et al.  Remotely Triggerable Drug Delivery Systems , 2010, Advanced materials.

[4]  Jtf Jos Keurentjes,et al.  Repetitive on-demand drug release by magnetic heating of iron oxide containing polymeric implants , 2012 .

[5]  E. Bekyarova,et al.  Room-temperature Magnetic Ordering in Functionalized Graphene , 2012, Scientific Reports.

[6]  S. A. Thomas,et al.  Anti-HIV drug distribution to the central nervous system. , 2004, Current pharmaceutical design.

[7]  S. Ayre.  New approaches to the delivery of drugs to the brain. , 1989, Medical hypotheses.

[8]  K. Widder,et al.  Magnetic guidance of drug‐carrying microspheres , 1978 .

[9]  Erkki Ruoslahti,et al.  Remotely Triggered Release from Magnetic Nanoparticles , 2007 .

[10]  H. Gendelman,et al.  Cell-mediated drug delivery , 2011, Expert opinion on drug delivery.

[11]  H. Gendelman,et al.  Cell-Mediated Drugs Delivery , 2011 .

[12]  L. Varatharajan,et al.  The transport of anti-HIV drugs across blood–CNS interfaces: Summary of current knowledge and recommendations for further research , 2009, Antiviral research.

[13]  D. Bueno-Baqués,et al.  Synthesis and characterization of novel CoFe2O4–BaTiO3 multiferroic core–shell-type nanostructures , 2010 .

[14]  A. Mocroft,et al.  Starting highly active antiretroviral therapy: why, when and response to HAART. , 2004, The Journal of antimicrobial chemotherapy.

[15]  Robert Langer,et al.  A magnetically triggered composite membrane for on-demand drug delivery. , 2009, Nano letters.

[16]  Richard C. Willson,et al.  High-Throughput Top-Down Fabrication of Uniform Magnetic Particles , 2012, PloS one.

[17]  J. Weinstein,et al.  Inhibition of HIV-1 in monocyte/macrophage cultures by 2',3'-dideoxycytidine-5'-triphosphate, free and in liposomes. , 1990, AIDS research and human retroviruses.

[18]  Jiangyu Li,et al.  Multiferroic CoFe2O4-Pb(Zr(0.52)Ti(0.48))O3 core-shell nanofibers and their magnetoelectric coupling. , 2011, Nanoscale.

[19]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[20]  S. Saxena,et al.  A global perspective on HIV/AIDS. , 2012, Science.

[21]  M. Nair,et al.  Magnetic nanoformulation of azidothymidine 5’-triphosphate for targeted delivery across the blood–brain barrier , 2010, International journal of nanomedicine.

[22]  Xin Huang,et al.  A Bacterial Protein Enhances the Release and Efficacy of Liposomal Cancer Drugs , 2006, Science.

[23]  P. Lin,et al.  Roles and mechanisms of human immunodeficiency virus protease inhibitor ritonavir and other anti-human immunodeficiency virus drugs in endothelial dysfunction of porcine pulmonary arteries and human pulmonary artery endothelial cells. , 2009, The American journal of pathology.

[24]  M. Weinand,et al.  A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. , 1997, Journal of immunology.

[25]  J. Dobson,et al.  Magnetic nanoparticles for gene and drug delivery , 2008, International journal of nanomedicine.

[26]  P. Bagla.  India. Negative report on GM crops shakes government's food agenda. , 2012, Science.